|
SupprelinDrug - Supprelin The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Histrelin Acetate
Strength -
EQ 1MG BASE/ML
Applicant -
SHIRE
New Drug Application (NDA) Number -
019836
Product Number -
003
Therapeutic Equivalence (TE) Code -
Approval Date -
Dec 24, 1991
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Shire Development Inc
Supprelin
Tral 25mg Tablet; Oral
Cyclaine 5% Solution; Topical Histamine Phosphate Eq 0.1mg Base/ml Injectable; Injection Histamine Phosphate Eq 0.2mg Base/ml Injectable; Injection Histamine Phosphate Eq 1mg Base/ml Injectable; Injection Vantas 50mg Implant; Subcutaneous Supprelin Eq 0.2mg Base/ml Injectable; Injection Supprelin Eq 0.5mg Base/ml Injectable; Injection Supprelin Eq 1mg Base/ml Injectable; Injection Mylaxen 20mg/ml Injectable; Injection NewDrugInformation |